Commonwealth Equity Services’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.73M Sell
163,035
-2,596
-2% -$43.5K ﹤0.01% 1756
2025
Q1
$2.55M Buy
165,631
+7,316
+5% +$112K ﹤0.01% 1741
2024
Q4
$3.49M Sell
158,315
-15,281
-9% -$337K 0.01% 1475
2024
Q3
$3.13M Buy
173,596
+10,826
+7% +$195K ﹤0.01% 1552
2024
Q2
$2.65M Sell
162,770
-107,533
-40% -$1.75M ﹤0.01% 1603
2024
Q1
$3.81M Sell
270,303
-38,072
-12% -$537K 0.01% 1348
2023
Q4
$3.22M Buy
308,375
+52,898
+21% +$552K 0.01% 1382
2023
Q3
$2.61M Buy
255,477
+12,587
+5% +$128K 0.01% 1432
2023
Q2
$1.83M Buy
242,890
+72,588
+43% +$547K ﹤0.01% 1684
2023
Q1
$1.51K Buy
170,302
+50,006
+42% +$443 ﹤0.01% 1745
2022
Q4
$1.1M Buy
120,296
+296
+0.2% +$2.7K ﹤0.01% 1908
2022
Q3
$968K Sell
120,000
-7,815
-6% -$63K ﹤0.01% 1916
2022
Q2
$961K Sell
127,815
-1,880
-1% -$14.1K ﹤0.01% 1930
2022
Q1
$1.22M Sell
129,695
-14,784
-10% -$139K ﹤0.01% 1848
2021
Q4
$1.16M Sell
144,479
-22,777
-14% -$182K ﹤0.01% 1881
2021
Q3
$1.63M Sell
167,256
-2,205
-1% -$21.5K ﹤0.01% 1570
2021
Q2
$1.68M Sell
169,461
-13,447
-7% -$133K ﹤0.01% 1549
2021
Q1
$2.11M Buy
182,908
+14,317
+8% +$165K 0.01% 1282
2020
Q4
$1.63M Buy
168,591
+9,381
+6% +$90.5K ﹤0.01% 1343
2020
Q3
$1.43M Sell
159,210
-25,832
-14% -$233K ﹤0.01% 1282
2020
Q2
$2.28M Sell
185,042
-2,965
-2% -$36.5K 0.01% 971
2020
Q1
$1.69M Buy
188,007
+25,428
+16% +$228K 0.01% 974
2019
Q4
$1.59M Sell
162,579
-6,961
-4% -$68.2K 0.01% 1160
2019
Q3
$1.17M Buy
169,540
+9,262
+6% +$63.7K 0.01% 1273
2019
Q2
$1.48M Buy
160,278
+5,068
+3% +$46.8K 0.01% 1118
2019
Q1
$2.43M Sell
155,210
-5,714
-4% -$89.6K 0.01% 837
2018
Q4
$2.48M Sell
160,924
-23,357
-13% -$360K 0.01% 752
2018
Q3
$3.97M Buy
184,281
+25,123
+16% +$541K 0.02% 611
2018
Q2
$3.87M Sell
159,158
-6,284
-4% -$153K 0.02% 598
2018
Q1
$2.83M Buy
165,442
+1,175
+0.7% +$20.1K 0.02% 695
2017
Q4
$3.11M Buy
164,267
+4,102
+3% +$77.7K 0.02% 643
2017
Q3
$2.82M Sell
160,165
-7,732
-5% -$136K 0.02% 642
2017
Q2
$5.58M Buy
167,897
+2,742
+2% +$91.1K 0.04% 404
2017
Q1
$5.3M Buy
165,155
+28,816
+21% +$925K 0.04% 399
2016
Q4
$4.94M Buy
136,339
+17,819
+15% +$646K 0.04% 385
2016
Q3
$5.45M Sell
118,520
-20,105
-15% -$925K 0.04% 348
2016
Q2
$6.96M Buy
138,625
+38,948
+39% +$1.96M 0.06% 290
2016
Q1
$5.33M Buy
99,677
+2,033
+2% +$109K 0.05% 331
2015
Q4
$6.41M Buy
97,644
+652
+0.7% +$42.8K 0.06% 286
2015
Q3
$5.48M Buy
96,992
+5,803
+6% +$328K 0.06% 295
2015
Q2
$5.39M Sell
91,189
-5,829
-6% -$344K 0.05% 311
2015
Q1
$6.04M Sell
97,018
-838
-0.9% -$52.2K 0.06% 269
2014
Q4
$5.63M Buy
97,856
+3,389
+4% +$195K 0.06% 266
2014
Q3
$5.08M Buy
94,467
+1,391
+1% +$74.8K 0.06% 273
2014
Q2
$4.88M Buy
93,076
+1,095
+1% +$57.4K 0.06% 286
2014
Q1
$4.86M Sell
91,981
-33,651
-27% -$1.78M 0.07% 267
2013
Q4
$5.04M Buy
125,632
+24,778
+25% +$993K 0.07% 255
2013
Q3
$3.81M Buy
100,854
+11,874
+13% +$449K 0.06% 285
2013
Q2
$3.49M Buy
+88,980
New +$3.49M 0.06% 288